Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Shares Issued (2016 - 2025)

Historic Shares Issued for Aytu Biopharma (AYTU) over the last 17 years, with Q2 2025 value amounting to $14.8 million.

  • Aytu Biopharma's Shares Issued rose 33892.34% to $14.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $18.2 million, marking a year-over-year increase of 14679.67%. This contributed to the annual value of $14.8 million for FY2025, which is 32803.58% up from last year.
  • Per Aytu Biopharma's latest filing, its Shares Issued stood at $14.8 million for Q2 2025, which was up 33892.34% from $3.4 million recorded in Q2 2024.
  • In the past 5 years, Aytu Biopharma's Shares Issued ranged from a high of $14.8 million in Q2 2025 and a low of -$1.0 million during Q2 2022
  • For the 5-year period, Aytu Biopharma's Shares Issued averaged around $4.9 million, with its median value being $3.4 million (2024).
  • Within the past 5 years, the most significant YoY rise in Aytu Biopharma's Shares Issued was 329283.39% (2022), while the steepest drop was 11273.74% (2022).
  • Aytu Biopharma's Shares Issued (Quarter) stood at $4.5 million in 2021, then plummeted by 74.39% to $1.2 million in 2022, then surged by 121.52% to $2.6 million in 2023, then surged by 31.92% to $3.4 million in 2024, then soared by 338.92% to $14.8 million in 2025.
  • Its Shares Issued was $14.8 million in Q2 2025, compared to $3.4 million in Q2 2024 and $2.6 million in Q2 2023.